Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clopidogrel and thrombopenia. A case report].

G Helft1, I Elalamy, C Laudy

  • 1Service de Réadaptation Cardiovasculaire, Lamotte-Beuvron (41), France. gerard.helft@psl.ap-hop-paris.fr

Annales De Cardiologie Et D'Angeiologie
|August 27, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision Measurement of Neutrino Oscillation Parameters with 10 Years of Data from the NOvA Experiment.

Physical review letters·2026
Same author

Dual-Baseline Search for Active-to-Sterile Neutrino Oscillations in NOvA.

Physical review letters·2025
Same author

Ensuring privacy protection in the era of big laparoscopic video data: development and validation of an inside outside discrimination algorithm (IODA).

Surgical endoscopy·2023
Same author

Diagnostic performance of MRI perfusion and spectroscopy for brainstem glioma grading.

European review for medical and pharmacological sciences·2022
Same author

Randomized comparison between perineural dexamethasone and combined perineural dexamethasone-dexmedetomidine for ultrasound-guided infraclavicular block.

Regional anesthesia and pain medicine·2022
Same author

Surgeon-performed pericapsular nerve group (PENG) block for total hip arthroplasty using the direct anterior approach: a cadaveric study.

Regional anesthesia and pain medicine·2022
Same journal

[Study of Sleep Apnea Syndrome in Patients with Chronic Heart Failure in the Cardiology Department at Yalgado Ouédraogo teaching hospital in 2024 and 2025].

Annales de cardiologie et d'angeiologie·2026
Same journal

[Impact of knowledge and practices of hygieno-dietetical measures in hypertensive people at the Abidjan cardiology institute].

Annales de cardiologie et d'angeiologie·2026
Same journal

[Correlation between carotid atheroma and DAS28 gamma GT score in rheumatoid arthritis in an African black population].

Annales de cardiologie et d'angeiologie·2026
Same journal

[Dobutamine stress echocardiography: Appropriateness of indications and protocol compliance. A single-centre report].

Annales de cardiologie et d'angeiologie·2026
Same journal

[Post-COVID postural orthostatic tachycardia syndrome: Documentation of a hyperadrenergic phenotype by comprehensive autonomic testing].

Annales de cardiologie et d'angeiologie·2026
Same journal

Urban-rural disparities in hypertension prevalence, screening, and control in South Kivu Province, eastern Democratic Republic of the Congo.

Annales de cardiologie et d'angeiologie·2026
See all related articles

Clopidogrel, a thienopyridine antiplatelet, can cause isolated profound thrombocytopenia. This adverse event occurred without bleeding or thrombotic complications in a patient undergoing coronary artery stenting.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hematology

Background:

  • Clopidogrel is a widely used antiplatelet medication crucial in preventing thrombotic events after coronary artery stenting.
  • Thienopyridine derivatives, including clopidogrel, are generally considered safe, but potential adverse effects require ongoing monitoring.
  • Thrombocytopenia, a decrease in platelet count, is a known but rare complication associated with clopidogrel therapy.

Observation:

  • This report details a case of isolated profound thrombocytopenia in a patient administered clopidogrel following coronary artery stenting.
  • The patient experienced a significant drop in platelet count but remained free of bleeding or thrombotic complications.
  • Clopidogrel was discontinued two weeks post-procedure, after which platelet counts likely normalized (though not explicitly stated).

Related Experiment Videos

Findings:

  • Clopidogrel administration can lead to isolated profound thrombocytopenia, a condition distinct from the more commonly discussed thrombotic thrombocytopenic purpura.
  • The absence of bleeding or thrombotic events highlights a specific presentation of clopidogrel-induced thrombocytopenia.
  • This case expands the known spectrum of hematological adverse events associated with clopidogrel.

Implications:

  • Clinicians should be vigilant for isolated thrombocytopenia as a potential adverse effect of clopidogrel, even in the absence of typical thrombotic complications.
  • Early recognition and discontinuation of clopidogrel may prevent more severe hematological outcomes.
  • This case underscores the importance of considering drug-induced thrombocytopenia in patients presenting with unexplained low platelet counts, particularly those on antiplatelet therapy.